Literature DB >> 12751637

Crystalline to amorphous transition of disodium hydrogen phosphate during primary drying.

Abira Pyne1, Koustuv Chatterjee, Raj Suryanarayanan.   

Abstract

PURPOSE: To monitor the phase transitions during freeze-drying of disodium hydrogen phosphate.
METHODS: The variable temperature sample stage of the X-ray diffractometer (XRD) was attached to a vacuum pump, which enabled the entire freeze-drying process to be carried out in the sample chamber. The phase transitions during the freeze-drying cycle were monitored in real time by XRD. Aqueous buffer solution (containing disodium hydrogen phosphate and sodium dihydrogen phosphate) was cooled at 2 degrees C/min from room temperature to -70 degrees C. It was then heated to -25 degrees C and subjected to primary drying for 2 h at a chamber pressure of approximately 100 mTorr, followed by secondary drying at -10 degrees C.
RESULTS: In the frozen solution, disodium hydrogen phosphate had crystallized as the dodecahydrate (Na2HPO4 x 12H2O) as was evident from its characteristic lines at approximately 5.37, 4.27, and 2.81 angstroms. Primary drying for 2 h resulted in ice sublimation, and the complete disappearance of the dodecahydrate peaks.
CONCLUSION: The dehydration of the crystalline dodecahydrate resulted in an amorphous anhydrate. Thus the amorphous nature of the end product is a result of phase transitions during the process and do not reflect the solid-state of the ingredients during the entire process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751637     DOI: 10.1023/a:1023445905372

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Effect of freezing on the pH and composition of sodium and potassium phosphate solutions; the reciprocal system KH2PO4-Na2-HPO4-H2O.

Authors:  L VAN DEN BERG; D ROSE
Journal:  Arch Biochem Biophys       Date:  1959-04       Impact factor: 4.013

Review 2.  Rational design of stable lyophilized protein formulations: some practical advice.

Authors:  J F Carpenter; M J Pikal; B S Chang; T W Randolph
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

3.  Salt precipitation during the freeze-concentration of phosphate buffer solutions.

Authors:  N Murase; F Franks
Journal:  Biophys Chem       Date:  1989-11       Impact factor: 2.352

4.  In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.

Authors:  Y Li; J Han; G G Zhang; D J Grant; R Suryanarayanan
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

5.  Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions.

Authors:  G Gómez; M J Pikal; N Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

6.  Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry.

Authors:  R K Cavatur; R Suryanarayanan
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

7.  Hydration and dehydration of crystalline and amorphous forms of raffinose.

Authors:  A Saleki-Gerhardt; J G Stowell; S R Byrn; G Zografi
Journal:  J Pharm Sci       Date:  1995-03       Impact factor: 3.534

8.  The effect of additives on the crystallization of cefazolin sodium during freeze-drying.

Authors:  Abira Pyne; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

  8 in total
  5 in total

1.  Influence of processing conditions on the physical state of mannitol--implications in freeze-drying.

Authors:  Xiangmin Liao; Rajesh Krishnamurthy; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2007-02       Impact factor: 4.200

2.  Crystallization of trehalose in frozen solutions and its phase behavior during drying.

Authors:  Prakash Sundaramurthi; Thomas W Patapoff; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

3.  Raffinose crystallization during freeze-drying and its impact on recovery of protein activity.

Authors:  Koustuv Chatterjee; Evgenyi Y Shalaev; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

4.  Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

5.  Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.

Authors:  Dushyant B Varshney; Prakash Sundaramurthi; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-03-27       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.